Advanced searches left 3/3

Cardioversion Atrial Fibrillation Anticoagulation - Europe PMC

Summarized by Plex Scholar
Last Updated: 02 May 2022

* If you want to update the article please login/register

Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center.

Conclusions The 515 patients, 351 were men and 164 were women, with a mean CHA 2 DS 2 VASc score of 2. 6 1. 6. With a decrease in the use of warfarin from 24% in 2015 to 10% in 2020, outpatient apixaban use increased from 10% in 2015 to 46% in 2020. Four patients on a DOAC with one of the 124 patients on warfarin were hospitalized in four patients, one of the 144 patients on warfarin and two of the 36 patients not receiving anticoagulation post cardioversion were in four patients with one of the three38 patients on a DOAC, one of the 124 patients on warfarin, and two of the 36 patients not receiving anticoagulation post cardioversion. There were seven major gastrointestinal bleeding events in patients on oral anticoagulation, of which four were on warfarin and three on DOACs, with four of whom were on warfarin. The 30-day ischemic stroke post cardioversion risk in patients admitted in the intensive care unit were low, and only in patients admitted to the intensive care unit.

Source link: https://europepmc.org/article/MED/35465085

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions